Remove 2010 Remove Banking Remove Clinical Trials Remove Microdosing
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. He is the founder of Apeiron Investment Group, his family office and merchant banking business. Rick Doblin, Ph.D, Matthew Johnson.